Tian'an Technology (00383) issues a profit warning, expecting the interim profit attributable to shareholders to be approximately HKD 30 million to HKD 60 million.

Zhongan Health (00383) announced that it expects the group to record a profit attributable to shareholders of approximately HKD 30 million to HKD 60 million for the six months ending June 30, 2026, compared to approximately HKD 12 million for the six months ended June 30, 2025. This is mainly due to (i) increased operating income from the medical segment; (ii) a decrease in non-cash fair value losses on investment properties; (iii) an increase in fair value gains on trading investments; however, this is partially offset by (iv) a decrease in net foreign exchange gains in the first half of 2025.